SYGNACEL Trademark

Trademark Overview


On Tuesday, August 8, 2023, a trademark application was filed for SYGNACEL with the United States Patent and Trademark Office. The USPTO has given the SYGNACEL trademark a serial number of 98121770. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, July 24, 2025. This trademark is owned by WARSAW ORTHOPEDIC, INC.. The SYGNACEL trademark is filed in the Pharmaceutical Products category with the following description:

biological tissue grafts
sygnacel

General Information


Serial Number98121770
Word MarkSYGNACEL
Filing DateTuesday, August 8, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, July 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and Servicesbiological tissue grafts

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 6, 2023
Primary Code005
First Use Anywhere DateFriday, February 28, 2025
First Use In Commerce DateFriday, February 28, 2025

Trademark Owner History


Party NameWARSAW ORTHOPEDIC, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarsaw, IN 46582

Party NameWARSAW ORTHOPEDIC, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarsaw, IN 46582

Trademark Events


Event DateEvent Description
Friday, August 11, 2023NEW APPLICATION ENTERED
Wednesday, September 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2024ASSIGNED TO EXAMINER
Tuesday, April 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, December 12, 2024SOU EXTENSION 1 FILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 9, 2025USE AMENDMENT FILED
Thursday, December 12, 2024SOU EXTENSION 1 GRANTED
Tuesday, June 3, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 24, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 24, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 10, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, June 3, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords


sygnacel grafts tissue biological